IDIOPATHIC HYPERSOMNIA
Clinical trials for IDIOPATHIC HYPERSOMNIA explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC HYPERSOMNIA trials appear
Sign up with your email to follow new studies for IDIOPATHIC HYPERSOMNIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests new sleep disorder medication
Disease control Recruiting nowThis study continues testing ALKS 2680 tablets for people with narcolepsy or idiopathic hypersomnia who completed earlier trials. Researchers want to see how safe the medication is over a longer period and whether its benefits last. Participants will take the tablets regularly to…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2, PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Extended trial tests sleep disorder Drug's Long-Term safety
Disease control Recruiting nowThis study continues testing the safety and effectiveness of ORX750 medication for people with narcolepsy or idiopathic hypersomnia who completed an earlier trial. It follows 90 participants to monitor long-term side effects and whether the drug continues to help with daytime sle…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial offers hope for people who Can't stay awake
Disease control Recruiting nowThis study is testing whether an investigational drug called HBS-301 can help control the main symptoms of idiopathic hypersomnia, a sleep disorder that causes severe daytime sleepiness, sleep inertia, and fatigue. About 248 adults with the condition will receive either the drug …
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New brain protein mimic aims to wake up sleep disorder patients
Disease control Recruiting nowThis study is testing a new drug called ORX750 in people with narcolepsy or idiopathic hypersomnia, conditions that cause severe daytime sleepiness. The main goals are to see if the drug is safe and how the body processes it. Researchers also want to find out if it can help peopl…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New brain chemical mimic could help people stay awake
Symptom relief Recruiting nowThis study is testing whether an experimental drug called TAK-360 can help adults with idiopathic hypersomnia stay awake and feel less sleepy during the day. TAK-360 works by mimicking a natural brain chemical called orexin that helps keep people alert. About 96 participants will…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Takeda • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
New pill aims to wake up people with extreme sleepiness disorder
Symptom relief Recruiting nowThis study is testing whether a new tablet called ALKS 2680 can safely reduce excessive daytime sleepiness in people with idiopathic hypersomnia, a disorder that causes severe sleepiness despite adequate sleep. About 96 participants will take either the medication or a placebo (i…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC